Latest newsLATEST NEWS

We aim to become one of the leading pharmaceutical companies and to do all in our power to help prevent infectious diseases.

READ MORE
Latest News2022/08/02
The National University of Asunción's Team Shared Phase III Study Data of MVC COVID-19 Vaccine
Latest News2022/06/09
Medigen Vaccine Biologics reports positive results from 200-dose bag for mass vaccination of COVID-19 vaccines

新冠肺炎疫苗COVID-19 VACCINE

MVC COVID-19 vaccine is a protein subunit vaccine that contains recombinant spike protein of SARS-CoV-2 virus and has been authorized for emergency use by the Taiwan Food and Drug Administration, Ministry of Health and Welfare.

READ MORE

研發與產品R&D AND PIPELINE

MVC focuses on global and regional infectious diseases,
and is committed to developing countermeasures for the prevention and treatment of emerging infectious diseases, including COVID-19 vaccine, Enterovirus A17 vaccine, and Dengue vaccine.

READ MORE

RECRUITINGJoin MVC !

Guarding human health is the most important belief of MVC.
The professional capabilities and enthusiasms of the staff are our most cherished assets.
We attach great importance to each staffs' values and welcome the passionate talents to join us.

JOIN US
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree